4 completed. 1 Early Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Corneal Epithelium Defect: new trials by email Literature Review of Corneal Epithelium Defect trials Research Report on Corneal Epithelium Defect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease MSC Secretome Eye Drops - Mesenchymal Stromal Cells, Cornea | Early Phase 1 | Completed | University of Illinois at Chicago | 9 | 2024-01-24 | 2026-10-07 |
| A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops lowe-dose ZKY001 eye drops, Medium-dose ZKY001 eye drops, placebo - Corneal Epithelium Defect | Phase 2 | Completed | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | 120 | 2022-08-03 | 2025-01-15 |
| Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3 Topical Insulin - Corneal Ulcer, Corneal Perforation | Completed | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 20 | 2018-10-01 | 2021-04-27 | |
| GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients 0.3% hypromellose - Corneal Epithelium Defect | Phase 4 | Completed | Augusta University | 80 | 2007-10-01 | 2016-03-07 |
Corneal Diseases (1) · Corneal Perforation (1) · Corneal Ulcer (1)
Eye Diseases (2) · Corneal Diseases (1) · Corneal Injuries (1) · Craniocerebral Trauma (1) · Eye Infections (1) · Eye Injuries (1) · Facial Injuries (1) · Infections (1) · Keratitis (1) · Nervous System Diseases (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Hypromellose Derivatives (1) · Insulin (1)
Augusta University (1) · Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. (1) · University of Illinois at Chicago (1) · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. (1)
United States (2) · China (1) · Portugal (1)
Ali R Djalilian, MD (1) · Charlotte E Joslin, OD, PhD (1) · David D Bogorad, M.D (1) · Elmer Y Tu, MD (1) · Xingtao Zhou (1)
1UG3EY031809-01 (1)